Published in Proc Natl Acad Sci U S A on July 20, 1999
Molecular basis for amyloid fibril formation and stability. Proc Natl Acad Sci U S A (2005) 3.00
Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc Natl Acad Sci U S A (2002) 2.01
Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc Natl Acad Sci U S A (2004) 1.83
Prediction of aggregation rate and aggregation-prone segments in polypeptide sequences. Protein Sci (2005) 1.80
Evidence of a role for lactadherin in Alzheimer's disease. Am J Pathol (2007) 1.28
Amyloid in the cardiovascular system: a review. J Clin Pathol (2005) 1.24
Proinflammation: the key to arterial aging. Trends Endocrinol Metab (2013) 1.07
Amyloid in surgical pathology. Virchows Arch (2003) 1.05
Current perspectives on cardiac amyloidosis. Am J Physiol Heart Circ Physiol (2011) 1.04
Characterization of novel breast carcinoma-associated BA46-derived peptides in HLA-A2.1/D(b)-beta2m transgenic mice. J Clin Invest (2002) 0.97
Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the Kunitz protease inhibitor. PLoS One (2008) 0.97
Hexafluoroisopropanol induces amyloid fibrils of islet amyloid polypeptide by enhancing both hydrophobic and electrostatic interactions. J Biol Chem (2011) 0.96
Amyloidogenic sequences in native protein structures. Protein Sci (2010) 0.91
The reality of aging viewed from the arterial wall. Artery Res (2013) 0.91
Comparisons with amyloid-β reveal an aspartate residue that stabilizes fibrils of the aortic amyloid peptide medin. J Biol Chem (2015) 0.84
Transbilayer phospholipids molecular imaging. EJNMMI Res (2011) 0.80
Comparison of aggregation enhancement and inhibition as strategies for reducing the cytotoxicity of the aortic amyloid polypeptide medin. Eur Biophys J (2010) 0.79
Milk fat globule epidermal growth factor VIII signaling in arterial wall remodeling. Curr Vasc Pharmacol (2013) 0.79
Oxidative Stress Alters the Morphology and Toxicity of Aortic Medial Amyloid. Biophys J (2015) 0.77
(1)H, (15)N and (13)C assignment of the amyloidogenic protein medin using fast-pulsing NMR techniques. Biomol NMR Assign (2015) 0.77
Can proteomics yield insight into aging aorta? Proteomics Clin Appl (2013) 0.76
Probing Medin Monomer Structure and its Amyloid Nucleation Using (13)C-Direct Detection NMR in Combination with Structural Bioinformatics. Sci Rep (2017) 0.75
The Reality of Aging Viewed from the Arterial Wall: An Interview with Dr. Edward Lakatta, Founder and Director of the Laboratory of Cardiovascular Science, National Institute on Aging. Pulse (Basel) (2013) 0.75
IgG Conformer's Binding to Amyloidogenic Aggregates. PLoS One (2015) 0.75
Smooth muscle titin forms in vitro amyloid aggregates. Biosci Rep (2016) 0.75
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem (1987) 59.79
Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell (1993) 10.15
The molecular pathology of Alzheimer's disease. Neuron (1991) 8.21
Rapid cDNA sequencing (expressed sequence tags) from a directionally cloned human infant brain cDNA library. Nat Genet (1993) 7.38
Conformational disease. Lancet (1997) 4.53
Seminars in medicine of the Beth Israel Hospital, Boston. beta-Amyloid and the pathogenesis of Alzheimer's disease. N Engl J Med (1991) 2.24
Role of human-milk lactadherin in protection against symptomatic rotavirus infection. Lancet (1998) 2.07
The discoidin domain family revisited: new members from prokaryotes and a homology-based fold prediction. Protein Sci (1998) 1.74
Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl Acad Sci U S A (1995) 1.60
Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis. J Clin Invest (1992) 1.60
Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc Natl Acad Sci U S A (1998) 1.58
Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain. Neuron (1995) 1.56
A novel missense mutation in the factor VIII gene identified by analysis of amplified hemophilia DNA sequences. Nucleic Acids Res (1987) 1.50
A Mr 46,000 human milk fat globule protein that is highly expressed in human breast tumors contains factor VIII-like domains. Cancer Res (1991) 1.50
Lactadherin (formerly BA46), a membrane-associated glycoprotein expressed in human milk and breast carcinomas, promotes Arg-Gly-Asp (RGD)-dependent cell adhesion. DNA Cell Biol (1997) 1.43
Elastic properties of human aortas in relation to age and atherosclerosis: a structural model. Phys Med Biol (1995) 1.28
Gelsolin-related amyloidosis. Identification of the amyloid protein in Finnish hereditary amyloidosis as a fragment of variant gelsolin. J Clin Invest (1991) 1.18
Inhibitory anti-factor V antibodies bind to the factor V C2 domain and are associated with hemorrhagic manifestations. Blood (1998) 1.08
Nomenclature of amyloid and amyloidosis. WHO-IUIS Nomenclature Sub-Committee. Bull World Health Organ (1993) 1.07
Cloning and expression of cDNA for O-acetylation of GD3 ganglioside. Biochem Biophys Res Commun (1996) 1.02
Apolipoprotein A1-derived amyloid in human aortic atherosclerotic plaques. Am J Pathol (1995) 1.00
Stage specific expression of milk fat globule membrane glycoproteins in mouse mammary gland: comparison of MFG-E8, butyrophilin, and CD36 with a major milk protein, beta-casein. Biochim Biophys Acta (1997) 0.98
Mechanisms of transthyretin amyloidogenesis. Antigenic mapping of transthyretin purified from plasma and amyloid fibrils and within in situ tissue localizations. Am J Pathol (1994) 0.97
Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein. Scand J Immunol (1998) 0.95
Extensive intimal apolipoprotein A1-derived amyloid deposits in a patient with an apolipoprotein A1 mutation. Biochem Biophys Res Commun (1998) 0.95
Senile aortic amyloid. Evidence for two distinct forms of localized deposits. Am J Pathol (1992) 0.93
The use of subcutaneous fat tissue for amyloid typing by enzyme-linked immunosorbent assay. Am J Clin Pathol (1999) 0.93
Islet amyloid polypeptide--a novel controversy in diabetes research. Diabetologia (1992) 0.92
Isolation and characterization of full and truncated forms of human breast carcinoma protein BA46 from human milk fat globule membranes. J Protein Chem (1998) 0.85
The prionoses and other conformational disorders. Amyloid (1998) 0.85
Islet amyloid polypeptide: demonstration of mRNA in human pancreatic islets by in situ hybridization in islets with and without amyloid deposits. Diabetologia (1993) 0.84
A novel missense mutation in exon 4 of the factor VIII:C gene resulting in moderately severe hemophilia A. Blood (1989) 0.81
Altered immunoreactivity of islet amyloid polypeptide (IAPP) may reflect major modifications of the IAPP molecule in amyloidogenesis. Diabetologia (1997) 0.81
[34] Modification of tryptophan with BNPS-skatole (2-(2-nitrophenylsulfenyl)-3-methyl-3-bromoindolenine). Methods Enzymol (1972) 0.80
Variable expression of tumor necrosis factor alpha in human malignant melanoma localized by in situ hybridization for mRNA. Cancer Immunol Immunother (1997) 0.78
The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat Neurosci (2001) 5.29
Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron (1996) 5.14
Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci U S A (1987) 4.53
Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci U S A (1990) 3.29
The L45 loop in type I receptors for TGF-beta family members is a critical determinant in specifying Smad isoform activation. FEBS Lett (1998) 3.00
Arrest of beta-amyloid fibril formation by a pentapeptide ligand. J Biol Chem (1996) 2.93
Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci U S A (1990) 2.87
Multiple forms of cytochrome c in the rat. Precursor-product relationship between the main component Cy I and the minor components Cy II and Cy 3 in vivo. J Biol Chem (1968) 2.76
Cloning and sequencing of the gene encoding the phosphatidylcholine-preferring phospholipase C of Bacillus cereus. Gene (1988) 2.74
A novel lactococcal bacteriocin whose activity depends on the complementary action of two peptides. J Bacteriol (1992) 2.58
Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling. J Biol Chem (1997) 2.39
The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia (1978) 2.31
A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun (1986) 2.24
Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med (1983) 2.13
Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbumin. Biochem Biophys Res Commun (1988) 2.13
A molecular model of Alzheimer amyloid beta-peptide fibril formation. J Biol Chem (1999) 2.12
Evidence for three separate genes encoding the proteins of the mycobacterial antigen 85 complex. Infect Immun (1990) 2.06
Purification and amino acid sequence of lactocin S, a bacteriocin produced by Lactobacillus sake L45. Appl Environ Microbiol (1991) 2.02
The complete amino-acid sequence of non-immunoglobulin amyloid fibril protein AS in rheumatoid arthritis. Eur J Biochem (1974) 2.02
Antigenic and chemical characterization of non-immunoglobulin amyloid proteins. Scand J Immunol (1972) 1.97
Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid. J Exp Med (1976) 1.91
Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. Proc Natl Acad Sci U S A (1994) 1.91
Isolation and characterization of pediocin L50, a new bacteriocin from Pediococcus acidilactici with a broad inhibitory spectrum. Appl Environ Microbiol (1995) 1.90
Purification and amino acid sequence of a bacteriocin produced by Pediococcus acidilactici. J Gen Microbiol (1992) 1.89
Senile cardiac amyloid is related to prealbumin. Scand J Immunol (1980) 1.86
Purification and N-terminal sequence of a fimbrial protein from Moraxella nonliquefaciens. FEBS Lett (1977) 1.81
Staining methods for identification of amyloid in tissue. Methods Enzymol (1999) 1.80
The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies. J Intern Med (2004) 1.74
Senile systemic amyloidosis. Am J Pathol (1984) 1.69
Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species. FEBS Lett (1989) 1.68
Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets. Diabetologia (1989) 1.66
Elucidation of the primary and three-dimensional structure of the uterotonic polypeptide kalata B1. Biochemistry (1995) 1.61
New biologically active hybrid bacteriocins constructed by combining regions from various pediocin-like bacteriocins: the C-terminal region is important for determining specificity. Appl Environ Microbiol (1996) 1.61
Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient. Diabetologia (1988) 1.60
Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol (1987) 1.60
Nomenclature of amyloid fibril proteins. Report from the meeting of the International Nomenclature Committee on Amyloidosis, August 8-9, 1998. Part 1. Amyloid (1999) 1.59
Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc Natl Acad Sci U S A (1998) 1.58
Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain. Neuron (1995) 1.56
The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. Eur J Immunol (1996) 1.53
Effects of beta cell granule components on human islet amyloid polypeptide fibril formation. FEBS Lett (1996) 1.49
Senile cardiac amyloidosis: evidence of two different amyloid substances in the ageing heart. Scand J Immunol (1979) 1.48
Fine structure of islets of Langerhans in insular amyloidosis. Virchows Arch A Pathol Pathol Anat (1973) 1.45
Amyloid in polypeptide hormone-producing tumors. Lab Invest (1977) 1.45
'Amylin' hormone. Nature (1989) 1.44
Controlling amyloid beta-peptide fibril formation with protease-stable ligands. J Biol Chem (1997) 1.43
Amyloid-related serum protein SAA from three animal species: comparison with human SAA. J Immunol (1977) 1.43
The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta Pathol Microbiol Scand A (1973) 1.43
Quantitative studies on amyloid in the islets of Langerhans. Ups J Med Sci (1972) 1.42
Chemical characterization of high potential iron proteins from Chromatium and Rhodopseudomonas gelatinosa. Biochim Biophys Acta (1967) 1.42
Amyloid fibril protein subunit, "protein AS": distribution in tissue and serum in different clinical types of amyloidosis including that associated with myelomatosis and Waldenström's macroglobulinamia. Scand J Immunol (1973) 1.41
In vivo conversion of L-serine to D-alanine in a ribosomally synthesized polypeptide. J Biol Chem (1994) 1.40
A new method for the diagnosis of systemic amyloidosis. Arch Intern Med (1973) 1.38
Amyloid in basal cell carcinoma and seborrheic keratosis. Acta Derm Venereol (1994) 1.38
Mutation of a Src phosphorylation site in the PDGF beta-receptor leads to increased PDGF-stimulated chemotaxis but decreased mitogenesis. EMBO J (1996) 1.37
Senile cerebral amyloid. Prealbumin as a common constituent in the neuritic plaque, in the neurofibrillary tangle, and in the microangiopathic lesion. Am J Pathol (1982) 1.36
Identification and characterization of different amyloid fibril proteins in tissue sections. Scand J Immunol (1977) 1.33
Some characteristics of phospholipase C from Bacillus cereus. Eur J Biochem (1977) 1.32
Characterization of an amyloid fibril protein from senile cardiac amyloid. J Exp Med (1977) 1.30
Unique amyloid protein subunit common to different types of amyloid fibril. Nature (1973) 1.30
Senile cardiac amyloid: evidence that fibrils contain a protein immunologically related to prealbumin. Immunology (1981) 1.30
Purification and characterization of a new bacteriocin isolated from a Carnobacterium sp. Appl Environ Microbiol (1992) 1.30
Purification and characterization of plantaricin A, a Lactobacillus plantarum bacteriocin whose activity depends on the action of two peptides. J Gen Microbiol (1993) 1.29
Diagnosis of secondary generalized amyloidosis by fine needle biopsy of the skin. Acta Med Scand (1971) 1.28
Cytochrome c2 of Rhodospirillum rubrum. II. Complete amino acid sequence and phylogenetic relationships. J Biol Chem (1968) 1.27
Transforming growth factor-beta 1, -beta 2, and -beta 3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes. J Biol Chem (1992) 1.27
Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase-antiperoxidase (PAP) and protein A-gold techniques. Am J Pathol (1988) 1.26
Amyloid beta-peptide polymerization studied using fluorescence correlation spectroscopy. Chem Biol (1999) 1.26
Normal transthyretin and synthetic transthyretin fragments form amyloid-like fibrils in vitro. Biochem Biophys Res Commun (1991) 1.25
New, third class of amyloid fibril protein. J Exp Med (1974) 1.25
Protein kinase C and cyclic AMP-dependent protein kinase phosphorylate phospholemman, an insulin and adrenaline-regulated membrane phosphoprotein, at specific sites in the carboxy terminal domain. Biochem J (1994) 1.24
Oldenlandia affinis (R&S) DC. A plant containing uteroactive peptides used in African traditional medicine. J Ethnopharmacol (2000) 1.23
Senile amyloidosis: a protean manifestation of the aging process. J Clin Pathol (1980) 1.22
The complete amino acid sequence of a prototype immunoglobulin-lambda light-chain-type amyloid-fibril protein AR. Biochem J (1981) 1.22
An unusually large (83 amino acid residues) amyloid fibril protein AA from a patient with Waldenström's macroglobulinaemia and amyloidosis. Scand J Immunol (1980) 1.21
The P-component of amyloid of human islets of langerhans. Scand J Immunol (1975) 1.20
Chemical typing of amyloid protein contained in formalin-fixed paraffin-embedded biopsy specimens. Am J Clin Pathol (2001) 1.19
Islet amyloid polypeptide (IAPP):cDNA cloning and identification of an amyloidogenic region associated with the species-specific occurrence of age-related diabetes mellitus. Exp Cell Res (1989) 1.19
Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours. J Endocrinol (1995) 1.18
Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice. Biochem Biophys Res Commun (1994) 1.18
Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines. Int J Pancreatol (1997) 1.17
The Alzheimer A beta peptide develops protease resistance in association with its polymerization into fibrils. J Biol Chem (1994) 1.17